Evaluating the efficacy of new inotropic agents
- 30 June 1984
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 3 (6) , 1570-1574
- https://doi.org/10.1016/s0735-1097(84)80299-5
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.Circulation, 1982
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Drug-induced conditioning in congestive heart failure.Circulation, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- Long-Term Digitalis Therapy Improves Left Ventricular Function in Heart FailureNew England Journal of Medicine, 1980
- Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.Circulation, 1979
- Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure.Circulation, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- A New Inotropic Drug: Its Promise and a CautionNew England Journal of Medicine, 1978